|
| 38079361 | Reply to "Contextualizing racial associations in prostate cancer to expose structural causes". | Cancer | 2024 |
| 36585434 | MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. | Prostate Cancer Prostatic Dis | 2023 |
| 37717923 | Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study. | Mod Pathol | 2023 |
| 37698493 | Racial differences in serum chemokines in prostate cancer patients. | Cancer | 2023 |
| 34753659 | Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. | Urol Oncol | 2022 |
| 36266514 | Ensuring remote diagnostics for pathologists: an open letter to the US Congress. | Nat Med | 2022 |
| 34949766 | Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. | Mod Pathol | 2022 |
| 34913878 | Large Cell Calcifying Sertoli Cell Tumor: A Clinicopathologic Study of 18 Cases With Comprehensive Review of the Literature and Reappraisal of Prognostic Features. | Am J Surg Pathol | 2022 |
| 34906585 | Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need. | Urology | 2022 |
| 34875014 | Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma. | Am J Clin Pathol | 2022 |
| 35322193 | p53 null phenotype is a "positive result" in urothelial carcinoma in situ. | Mod Pathol | 2022 |
| 32948433 | Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. | Urol Oncol | 2021 |
| 33630025 | Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors. | JAMA Oncol | 2021 |
| 33683724 | Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India. | Prostate | 2021 |
| 33586037 | De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome. | Med Oncol | 2021 |
| 33528621 | AI reality check when evaluating difficult to grade prostate cancers. | Virchows Arch | 2021 |
| 34522463 | Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations. | Am J Cancer Res | 2021 |
| 34128484 | The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. | Adv Anat Pathol | 2021 |
| 34128483 | The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. | Adv Anat Pathol | 2021 |
| 34337531 | Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study. | Eur Urol Open Sci | 2021 |
| 33080150 | Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. | J Urol | 2021 |
| 32631746 | Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. | Eur Urol | 2021 |
| 32589068 | The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. | Arch Pathol Lab Med | 2021 |
| 31420496 | <sup>18</sup>F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies. | J Nucl Med | 2020 |
| 31876580 | Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. | Am J Surg Pathol | 2020 |
| 31872452 | Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature. | Histopathology | 2020 |
| 32777370 | Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice. | Urology | 2020 |
| 32576626 | The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. | Clin Cancer Res | 2020 |
| 32673685 | Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin. | Hum Pathol | 2020 |
| 31061129 | Genomic correlates of clinical outcome in advanced prostate cancer. | Proc Natl Acad Sci U S A | 2019 |
| 31350321 | <sup>18</sup>F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis. | J Nucl Med | 2019 |
| 31376196 | Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer. | Prostate | 2019 |
| 29309300 | Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. | Am J Surg Pathol | 2018 |
| 29915428 | A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. | Nat Genet | 2018 |
| 29808028 | Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. | Nat Genet | 2018 |
| 29906450 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. | Cell | 2018 |
| 29878933 | Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists. | Am J Surg Pathol | 2018 |
| 30622835 | Computer-Aided Laser Dissection: A Microdissection Workflow Leveraging Image Analysis Tools. | J Pathol Inform | 2018 |
| 29744932 | Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer. | Prostate | 2018 |
| 29589155 | Accuracy of tumor segmentation from multi-parametric prostate MRI and <sup>18</sup>F-choline PET/CT for focal prostate cancer therapy applications. | EJNMMI Res | 2018 |
| 29261439 | Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. | J Clin Oncol | 2018 |
| 27550065 | Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer. | Prostate | 2017 |
| 28315424 | Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. | Hum Pathol | 2017 |
| 28302759 | Preclinical Evaluation of <sup>11</sup>C-Sarcosine as a Substrate of Proton-Coupled Amino Acid Transporters and First Human Application in Prostate Cancer. | J Nucl Med | 2017 |
| 28423517 | Next generation sequencing of extraskeletal myxoid chondrosarcoma. | Oncotarget | 2017 |
| 28783718 | Integrative clinical genomics of metastatic cancer. | Nature | 2017 |
| 28751446 | Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification. | Clin Cancer Res | 2017 |
| 28031426 | Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer. | Clin Cancer Res | 2017 |
| 25985884 | Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. | Eur Urol | 2016 |
| 32259162 | Testicular Size Discrepancy in a Man Evaluated for Vasectomy. | Am J Urol Res | 2016 |